BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38015851)

  • 1. A molecular mechanism for the "digital" response of p53 to stress.
    Safieh J; Chazan A; Saleem H; Vyas P; Danin-Poleg Y; Ron D; Haran TE
    Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2305713120. PubMed ID: 38015851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symphony of the DNA flexibility and sequence environment orchestrates p53 binding to its responsive elements.
    Vanaja A; Mallick SP; Kulandaivelu U; Kumar A; Yella VR
    Gene; 2021 Nov; 803():145892. PubMed ID: 34375633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complex architecture of p53 binding sites.
    Senitzki A; Safieh J; Sharma V; Golovenko D; Danin-Poleg Y; Inga A; Haran TE
    Nucleic Acids Res; 2021 Feb; 49(3):1364-1382. PubMed ID: 33444431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional evolution of the p53 regulatory network through its target response elements.
    Jegga AG; Inga A; Menendez D; Aronow BJ; Resnick MA
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):944-9. PubMed ID: 18187580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression based predictor for p53 transactivation.
    Gowrisankar S; Jegga AG
    BMC Bioinformatics; 2009 Jul; 10():215. PubMed ID: 19602281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of chromatin context, binding site sequence content, and sequence evolution in stress-induced p53 occupancy and transactivation.
    Su D; Wang X; Campbell MR; Song L; Safi A; Crawford GE; Bell DA
    PLoS Genet; 2015 Jan; 11(1):e1004885. PubMed ID: 25569532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-genome cartography of p53 response elements ranked on transactivation potential.
    Tebaldi T; Zaccara S; Alessandrini F; Bisio A; Ciribilli Y; Inga A
    BMC Genomics; 2015 Jun; 16(1):464. PubMed ID: 26081755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure formed by inverted repeats in p53 response elements determines the transactivation activity of p53 protein.
    Brázda V; Čechová J; Battistin M; Coufal J; Jagelská EB; Raimondi I; Inga A
    Biochem Biophys Res Commun; 2017 Jan; 483(1):516-521. PubMed ID: 28007599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncanonical DNA motifs as transactivation targets by wild type and mutant p53.
    Jordan JJ; Menendez D; Inga A; Noureddine M; Bell DA; Resnick MA
    PLoS Genet; 2008 Jun; 4(6):e1000104. PubMed ID: 18714371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence.
    Inga A; Storici F; Darden TA; Resnick MA
    Mol Cell Biol; 2002 Dec; 22(24):8612-25. PubMed ID: 12446780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation.
    Tomso DJ; Inga A; Menendez D; Pittman GS; Campbell MR; Storici F; Bell DA; Resnick MA
    Proc Natl Acad Sci U S A; 2005 May; 102(18):6431-6. PubMed ID: 15843459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53 family members modulate the expression of PRODH, but not PRODH2, via intronic p53 response elements.
    Raimondi I; Ciribilli Y; Monti P; Bisio A; Pollegioni L; Fronza G; Inga A; Campomenosi P
    PLoS One; 2013; 8(7):e69152. PubMed ID: 23861960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-level p53 expression changes transactivation rules and reveals superactivating sequences.
    Jordan JJ; Menendez D; Sharav J; Beno I; Rosenthal K; Resnick MA; Haran TE
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14387-92. PubMed ID: 22908277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent evolution of human p53 binding sites: cell cycle versus apoptosis.
    Horvath MM; Wang X; Resnick MA; Bell DA
    PLoS Genet; 2007 Jul; 3(7):e127. PubMed ID: 17677004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences.
    Menendez D; Inga A; Resnick MA
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1500-5. PubMed ID: 20080630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiating the p53 network.
    Menendez D; Inga A; Resnick MA
    Discov Med; 2010 Jul; 10(50):94-100. PubMed ID: 20670604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of p53 transactivation specificity through the lens of a yeast-based functional assay.
    Lion M; Raimondi I; Donati S; Jousson O; Ciribilli Y; Inga A
    PLoS One; 2015; 10(2):e0116177. PubMed ID: 25668429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts.
    Noureddine MA; Menendez D; Campbell MR; Bandele OJ; Horvath MM; Wang X; Pittman GS; Chorley BN; Resnick MA; Bell DA
    PLoS Genet; 2009 May; 5(5):e1000462. PubMed ID: 19424414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive and high-resolution genome-wide response of p53 to stress.
    Chang GS; Chen XA; Park B; Rhee HS; Li P; Han KH; Mishra T; Chan-Salis KY; Li Y; Hardison RC; Wang Y; Pugh BF
    Cell Rep; 2014 Jul; 8(2):514-27. PubMed ID: 25043190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity.
    Resnick MA; Inga A
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9934-9. PubMed ID: 12909720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.